Human immunodeficiency virus (HIV) is considered to be the major aetiological agent of AIDS. The most prominent symptom of AIDS is chronic progressive depletion of T lymphocytes bearing CD4 cell-surface markers. Although it is not clear how the infection causes the gradual depletion of CD4 + T lymphocytes, the ability of HIV to injure or kill CD4 + T cells has long been considered a major pathogenic property (Levy, 1993) . Some evidence indicates that direct cytopathogenicity caused by HIV infection contributes to CD4 + T cell depletion in AIDS patients. The cytopathology for CD4 + cells infected by HIV is observed as the formation of syncytia and\or single-cell killing (Levy, 1993) although cell killing can Author for correspondence : Akinori Ishimoto.
Fax j81 75 751 3995. e-mail aishimot!virus.kyoto-u.ac.jp occur even without syncytia formation (Cloyd & Moore, 1990 ; Dedera & Ratner, 1991 ; Koga et al., 1994) . HIV envelope glycoproteins (gp120 and gp41) and cell-surface CD4 are involved in syncytia formation (Freed et al., 1991 ; Hussey et al., 1988 ; Lifson et al., 1986) . Both syncytial and single cells undergo ' ballooning degeneration ' in which the volume of the infected cells increases beyond the limits of the plasma membrane's ability to maintain its integrity (Levy, 1993) . The earliest ' lesion ' is due to an increase in plasma membrane permeability (Cloyd & Lynn, 1991 ; Lynn et al., 1988) .
It has been reported that HIV variants with increased cytopathic potential are the dominant types that emerge during progression to the late stages of HIV infection (ChengMayer et al., 1988 ; Fenyo et al., 1988) . Increases in virus production correlate with the accelerated loss of CD4 + T cells, further supporting the finding that direct HIV-mediated cytopathogenicity causes the depletion of CD4 + T cells in AIDS (Ho et al., 1995 ; Wei et al., 1995) . The cytopathic properties of HIV are highly dependent on the HIV isolate, cell type and concentration (m.o.i.) of virus (Cloyd & Moore, 1990 ; Dedera & Ratner, 1991) . Detailed analysis of the factors that determine the cytopathic effect (CPE) may provide important information on HIV pathogenicity.
We previously described a panel of biologically cloned isolates that differed significantly in their biological properties, including their CPE (Cloyd & Moore, 1990) . The diversity of each HIV isolate may reflect its virulence in vivo as well. To investigate the determinant(s) of their CPE(s), we studied two diverse isolates, HIV pm#"$ and HIV MCK . Isolation and characterization of these two HIV isolates has been reported elsewhere (Cloyd & Moore, 1990 transfected with the infectious DNAs. The abilities of these viruses to induce CPE were similar to those of the original isolates (Cloyd & Moore, 1990) . HIV #"$ was highly cytopathic, while HIV MCK induced little cytopathicity (see Fig. 1 b) . To determine which gene(s) is responsible for the differences in cytopathicity, we constructed a series of chimeric viruses (Fig.  1 a) and cytopathicities were monitored based on their cell viability (measured by trypan blue exclusion) compared with mock-infected cells. Fig. 1 (b) shows the cytopathicity induced by each chimeric virus after infection of CEM cells at an m.o.i. of 0n01. As shown in Fig. 1 (b) , the degree of cytopathicity induced by the chimeric viruses was classified into two types : as strong as that of HIV MCK wild-type (HIV MCK WT) or the same as that of HIV #"$ wild-type (HIV #"$ WT) (shown as MCK WT and 213 WT, respectively, in Fig. 1 b) . These data indicate that chimeric viruses (HIV MCK SP, HIV MCK NX, HIV #"$ SX, HIV #"$ SN and HIV #"$ PN) having the PleI-NdeI fragment derived from HIV MCK were less cytopathic. Moreover, these viruses induced smaller and fewer syncytia (data not shown).
DNA sequence comparison of a PleI-NdeI region in HIV MCK and HIV #"$ showed that there were some mismatched nucleotides. Significantly, the codon for the translational start position of Vpu in HIV #"$ appeared to be ACG instead of ATG (Fig. 1 c) . To check whether the expression of Vpu protein was disrupted by the mutation, Western blot analysis was performed with a mixture of both anti-Vpu rabbit serum and antip24 MAb (Fig. 1 d) . Fig. 1 (c) indicates that HIV MCK wild-type and the chimeric virus HIV #"$ PN express Vpu proteins in infected cells. In contrast, HIV #"$ wild-type and HIV MCK PN do not express Vpu. As these results are consistent with the nucleotide sequence data, it seems that expression of Vpu protein was disturbed by the mutation occurring in HIV #"$ . Therefore, the difference in CPE between HIV MCK and HIV #"$ appears to depend on the expression of Vpu protein.
It has been reported that Vpu performs two independent functions : (i) intracellular degradation of CD4, and (ii) enhancement of virus release. To gain insight into which biological activity of Vpu contributes to the reduced CPE, the concentrations of envelope glycoprotein and CD4 on the infected-cell surface were monitored. Flow-cytometry intensity measurements with anti-HIV-1 envelope glycoprotein polyclonal antibody showed that the concentration of envelope glycoprotein on the surface of cells infected with HIV MCK PN (Vpu-deficient) virus was 4-fold greater than that with HIV MCK WT (Vpu-positive) virus (Fig. 2 a) . Similarly, the concentration of the envelope glycoprotein on cells infected with HIV #"$ WT (Vpu-deficient) virus was double that with HIV #"$ PN (Vpu-positive). We could not detect significant differences in the CD4 concentrations on the surface of cells infected with Vpu-positive and Vpu-deficient viruses, although the CD4 expression level of both was greatly reduced compared with mock-infected cells (data not shown). These results suggest that the reduced cytopathicity of HIV MCK compared with that of HIV #"$ is due to a decreased concentration of the envelope glycoprotein on the cell surface as a result of Vpu action.
To investigate the contribution of Vpu in reducing the concentration of envelope glycoprotein, we performed pulsechase studies. Infected CEM cells were pulse-labelled with [$&S]methionine and [$&S]cysteine (500 µCi\ml, Tran$&S-Label ; ICN Biochemical) for 20 min. At the indicated times, cells were collected and stored on dry ice. To study virus particle release, the supernatants were filtered through a 0n45 µm filter and cellfree virus particles were pelleted in 1n5 ml microtubes (4 mC, 120 min, 16 000 g). The cells and pelleted virus particles were lysed in a RIP buffer [150 mM NaCl, 50 mM Tris-HCl (pH 8n0), 1 % NP40, 0n5 % sodium deoxycholate, 0n1 % SDS, Leupeptin (1 µg\ml), and PMSF (50 µg\ml)]. Proteins immunoprecitated with AIDS patients' sera from cells and virion lysates were separated on a 10 % polyacrylamide gel. The gel was exposed to X-Omat AR film (Eastman Kodak). This experiment significantly showed that HIV MCK WT, which expresses Vpu, could efficiently release virus particles (Fig. 2 b) . In contrast, virus secretion from the cells infected with HIV MCK PN, which did not express Vpu, was less efficient (Fig. 2 b) . This effect of Vpu was greater than that reported by Schubert & Strebel (1994) . This difference might be due to the shorter chaseperiod in our experiment. We could not detect any difference in the amount of envelope glycoprotein synthesized de novo, suggesting that mutation of the Vpu start codon did not significantly affect the translational efficiency of the envelope glycoprotein, which was encoded by the bicistronic Vpu-Env mRNA. These results suggest that Vpu increases the rate of virus release from infected CEM cells. In the absence of Vpu, the majority of virus proteins, including envelope glycoproteins, remained cell-associated (Fig. 2 b) .
It is possible that the increased concentration of envelope (Env) protein at the plasma membrane in the absence of Vpu represents that of nascent virions themselves. Transmission electron microscopy (TEM) examination of these cells showed that far more virus particles remained associated at the plasma membrane in the absence of Vpu (Fig. 3 a-c) . The accumulation of virions on the cell surface in the absence of Vpu has also been reported by others (Klimkait et al., 1990) . With more detailed observation, many connected (chained) virions were found to be attached to the plasma membrane and\or to other budding progeny virions without Vpu (Fig. 3 b-f) . These chained viruses appeared to be associated through a short stalk (Fig. 3 d-f, indicated by arrows) . The results presented in Fig. 3 suggest that most of the virus proteins that remained cellassociated in the absence of Vpu consisted of virions attached to the plasma membrane.
Vpu is a 16 kDa integral membrane phosphoprotein which has been shown to induce CD4 degradation in the endoplasmic reticulum (ER) (Cohen et al., 1988 ; Willey et al., 1992 Willey et al., , 1994 and, independently, to augment the release of progeny virions from infected cells (Klimkait et al., 1990 ; Schubert et al., 1996 ; Terwilliger et al., 1989) . There are at least three explanations as to how Vpu contributes to the regulation of virus cytopathicity. Firstly, in the absence of Vpu, more CD4 may be expressed at the infected-cell surface due to reduced CD4 degradation in the ER. At the surface of the infected cells, the CD4 molecules might interact with virus envelope proteins (gp120 and gp41), which would cause cytopathic effects. Secondly, as Vpu protein is translated from a bicistronic mRNA, Vpu might modify the efficiency of de novo synthesis of the Env protein. On this point, we could not detect significant effects on Env protein synthesis due to mutation of the Vpu start codon (Fig. 2 b) . Thirdly, Vpu may enhance the export of cytotoxic viral gp120 and gp41 as a consequence of the augmentation of virus release. According to flow cytometric analysis, the concentration of the envelope glycoprotein on the surface of the cells infected with Vpu-deficient viruses was significantly higher than that of cells infected with Vpupositive viruses (Fig. 2 a) , which is consistent with a previous report based on an isogenic Vpu-deficient virus (Yao et al., 1993) . Although we failed to detect a significant difference in CD4 receptor levels because the CD4 levels on the surface of cells infected with either virus were far lower than those of mock-infected cells (data not shown), we could not exclude the possibility that CD4 down-modulation involves a differential CPE. These findings support the notion that the increased cytopathicity of HIV #"$ is due to an increased concentration of cell-surface envelope glycoprotein. Kinetic analysis and the TEM data suggest that the increased concentration of envelope glycoprotein accumulating on the infected-cell surface was derived from Vpu-deficient virus particles.
Morphological observations by TEM showed that in the absence of Vpu a significant number of the progeny particles were connected to the budding particles as chained viruses. Short stalks connecting each particle seemed to originate from within the cells. Vpu may function in the final process of virus release by constricting the stalk, leading to the separation of a virion from a virus-producing cell. The ultralocalization of Vpu at the HIV release point might be helpful in clarifying the Vpu effect on virion release.
The phenotypic differences between the two isolates isolated from AIDS patients correspond to those of Vpu mutants constructed by gene-engineering (Yao et al., 1993) . However, we showed that Vpu function can modulate avirulence even in individual HIV-1 strains in vitro. These results also imply that the function of Vpu contributes to the IEF Y. Iwatani and others Y. Iwatani and others modification of cytopathicity in vitro and pathogenicity in vivo of HIV-1. The fact that Vpu-deficient virions are tightly associated with the cell surface indicates the possibility that Vpu can convert the mode of virus transmission. In the absence of Vpu cell-to-cell transmission might be facilitated by the cellassociated virions. More detailed analysis of Vpu function is important for understanding the progression of HIV infection in vivo and AIDS.
